67 related articles for article (PubMed ID: 11061561)
1. Expression of pro-EPIL peptides encoded by the insulin-like 4 (INSL4) gene in chromosomally abnormal pregnancies.
Mock P; Frydman R; Bellet D; Chassin D; Bischof P; Campana A; Bidart JM
J Clin Endocrinol Metab; 2000 Oct; 85(10):3941-4. PubMed ID: 11061561
[TBL] [Abstract][Full Text] [Related]
2. Pro-EPIL forms are present in amniotic fluid and maternal serum during normal pregnancy.
Mock P; Frydman R; Bellet D; Diawara DA; Lavaissiere L; Troalen F; Bidart JM
J Clin Endocrinol Metab; 1999 Jun; 84(6):2253-6. PubMed ID: 10372742
[TBL] [Abstract][Full Text] [Related]
3. Identification of pro-EPIL and EPIL peptides translated from insulin-like 4 (INSL4) mRNA in human placenta.
Bellet D; Lavaissiere L; Mock P; Laurent A; Sabourin JC; Bedossa P; Le Bouteiller P; Frydman R; Troalen F; Bidart JM
J Clin Endocrinol Metab; 1997 Sep; 82(9):3169-72. PubMed ID: 9284764
[TBL] [Abstract][Full Text] [Related]
4. Cloning of a new member of the insulin gene superfamily (INSL4) expressed in human placenta.
Chassin D; Laurent A; Janneau JL; Berger R; Bellet D
Genomics; 1995 Sep; 29(2):465-70. PubMed ID: 8666396
[TBL] [Abstract][Full Text] [Related]
5. Amniotic fluid levels of human chorionic gonadotropin and its alpha and beta subunits in second-trimester chromosomally abnormal pregnancies.
Wolf GC; Byrn FW; McConnell TS; Khazaeli MB
Prenat Diagn; 1992 Feb; 12(2):93-101. PubMed ID: 1372734
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum placental protein 13 at eleven to thirteen weeks in chromosomally abnormal pregnancies.
Akolekar R; Pérez Penco JM; Skyfta E; Rodríguez Calvo J; Nicolaides KH
Fetal Diagn Ther; 2010; 27(2):72-7. PubMed ID: 20332643
[TBL] [Abstract][Full Text] [Related]
7. Early placenta insulin-like growth factor (pro-EPIL) is overexpressed and secreted by c-erbB-2-positive cells with high invasion potential.
Brandt B; Roetger A; Bidart JM; Packeisen J; Schier K; Mikesch JH; Kemming D; Boecker W; Yu D; Buerger H
Cancer Res; 2002 Feb; 62(4):1020-4. PubMed ID: 11861376
[TBL] [Abstract][Full Text] [Related]
8. Changes in the maternal serum concentration of proearly placenta insulin-like growth factor peptides in normal vs abnormal pregnancy.
Bruni L; Luisi S; Ferretti C; Janneau JL; Quadrifoglio M; Richon S; Dangles-Marie V; Bellet D; Petraglia F
Am J Obstet Gynecol; 2007 Dec; 197(6):606.e1-4. PubMed ID: 18060948
[TBL] [Abstract][Full Text] [Related]
9. Abnormal maternal serum levels of human chorionic gonadotropin free subunits in trisomy 18.
Ozturk M; Milunsky A; Brambati B; Sachs ES; Miller SL; Wands JR
Am J Med Genet; 1990 Aug; 36(4):480-3. PubMed ID: 2389806
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and proteolyzed IGFBP-3 in embryonic cavities in early human pregnancy: their potential relevance to maternal-embryonic and fetal interactions.
Nonoshita LD; Wathen NC; Dsupin BA; Chard T; Giudice LC
J Clin Endocrinol Metab; 1994 Nov; 79(5):1249-55. PubMed ID: 7525630
[TBL] [Abstract][Full Text] [Related]
11. Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
Spencer K; Crossley JA; Aitken DA; Nicolaides KH
Prenat Diagn; 2005 May; 25(5):358-61. PubMed ID: 15906423
[TBL] [Abstract][Full Text] [Related]
12. Placental mRNA expression of alpha and beta human chorionic gonadotrophin in early trisomy 18 pregnancies.
Brizot ML; Jauniaux E; Mckie AT; Farzaneh F; Nicolaides KH
Mol Hum Reprod; 1996 Jun; 2(6):463-5. PubMed ID: 9238717
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum hCG and SP1 in pregnancies with fetal aneuploidy.
Bartels I; Thiele M; Bogart MH
Am J Med Genet; 1990 Oct; 37(2):261-4. PubMed ID: 2147362
[TBL] [Abstract][Full Text] [Related]
14. Early placental insulin-like protein (INSL4 or EPIL) in placental and fetal membrane growth.
Millar L; Streiner N; Webster L; Yamamoto S; Okabe R; Kawamata T; Shimoda J; Büllesbach E; Schwabe C; Bryant-Greenwood G
Biol Reprod; 2005 Oct; 73(4):695-702. PubMed ID: 15958731
[TBL] [Abstract][Full Text] [Related]
15. Inhibin-B and pro-alphaC-containing inhibins in amniotic fluid from chromosomally normal and Down syndrome pregnancies.
Wallace EM; Crossley JA; Riley SC; Balfour C; Groome NP; Aitken DA
Prenat Diagn; 1998 Mar; 18(3):213-7. PubMed ID: 9556037
[TBL] [Abstract][Full Text] [Related]
16. Biochemical markers of trisomy 21 in amniotic fluid.
Spencer K; Muller F; Aitken DA
Prenat Diagn; 1997 Jan; 17(1):31-7. PubMed ID: 9021826
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of human placental growth hormone in the amniotic fluid of pregnancies affected by Down syndrome.
Sifakis S; Papadopoulou E; Konstantinidou A; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
Growth Horm IGF Res; 2009 Apr; 19(2):121-5. PubMed ID: 18793862
[TBL] [Abstract][Full Text] [Related]
18. Correlation between fetal sex and human chorionic gonadotropin in peripheral maternal blood and amniotic fluid in second and third trimester normal pregnancies.
Steier JA; Myking OL; Bergsjø PB
Acta Obstet Gynecol Scand; 1999 May; 78(5):367-71. PubMed ID: 10326878
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy specific beta 1-glycoprotein and human chorionic gonadotrophin levels n amniotic fluid and maternal serum in the first half of pregnancy.
Heikinheimo M; Seppälä M; Brock DJ
Oncodev Biol Med; 1980 Aug; 1(1):71-6. PubMed ID: 6974343
[TBL] [Abstract][Full Text] [Related]
20. Prenatal diagnosis of uniparental disomy 15 following trisomy 15 mosaicism.
Christian SL; Smith AC; Macha M; Black SH; Elder FF; Johnson JM; Resta RG; Surti U; Suslak L; Verp MS; Ledbetter DH
Prenat Diagn; 1996 Apr; 16(4):323-32. PubMed ID: 8734806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
